Dr. Brian I. Rini, MD

Dr. Rini practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Rini's NPI, 1144261231, was assigned on June 9, 2006. Dr. Rini graduated from Ohio State University College of Medicine in 1995. Dr. Rini holds Tennessee license 60288.

Dr. Rini's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Rini's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Rini is also affiliated with Cookeville Regional Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Rini to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rini practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rini's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rini is licensed in Tennessee.

CMS data shows 449 Medicare services from Dr. Rini across 6 procedure codes in 2024, for 192 Medicare patients. Medicare paid $44,583 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Rini in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rini's median patient age at 72, with 23% women.

In 2024, Dr. Rini wrote 833 Medicare Part D claims for 95 patients. 47% of them were for generic drugs. CMS names the drug for 721 of them, across 16 drugs with 11 or more claims each, at $6,487,791 in total drug cost. In 2023, CMS named 664 claims across 16 drugs.

Dr. Rini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rini as offering telehealth.

Dmand AI links 70 papers to Dr. Rini, published from 2012 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Sunitinib. Dr. Rini has published most often in Eur Urol. Dr. Rini's most frequent co-authors are Toni K. Choueiri, MD, Robert J. Motzer, MD and Michael B. Atkins, MD.

CMS Open Payments shows 488 general payments to Dr. Rini from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Merck Sharp & Dohme Corporation paid the most, $298,497. It also lists 10 research payments totaling $11,136 from 2017 to 2024.

Dr. Rini graduated from Ohio State University College of Medicine in 1995.